IntrinsicIntrinsic

Other Events ·

Revelation Biosciences, Inc. adopted a stockholder rights plan (poison pill) poison pill and entered into a Rights…

REVBRevelation Biosciences, Inc.

Revelation Biosciences, Inc. adopted a stockholder rights plan (poison pill) poison pill and entered into a Rights Agreement with Continental Stock Transfer & Trust Co. to prevent an acquiring person from reaching 10% ownership. The company declared a dividend of one preferred share purchase right per common stock share, with a record date of July 21, 2026. Revelation Biosciences, Inc. is a biotechnology company focused on developing immune-based therapies.

More from Revelation Biosciences, Inc.

Explore REVB